![]() Reddy M., Jugnee N., El Laboudi A., Spanudakis E., Anantharaja S., Oliver N. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes. Haak T., Hanaire H., Ajjan R., Hermanns N., Riveline J.-P., Rayman G. Novel glucose-sensing technology and hypoglycaemia in type 1 di-abetes: A multicentre, non-masked, randomised controlled trial. The subjects with poorer glycemic control and those who seldom performed SMBG benefited the most.įreeStyle Libre diabetes type 1 education glycemic control real life settings.īolinder J., Antuna R., Geelhoed-Duijvestijn P., Kröger J., Weitgasser R. The improvement in HbA1c was mainly driven by the increase in the number of scans per day. Also, in individuals performing SMBG less than 5 times per day, there was a steady decrease in HbA1c levels up to 6 months ( p < 0.05 and p < 0.001, respectively) as opposed to those who performed SMBG ≥5 times per day. The change in HbA1c values in the entire cohort was driven by change in the subgroup of patients with HbA1c ≥7% with a drop from 8.22% ± 1.14% to 7.68% ± 1.26% ( p < 0.0001) in the first 3 months. There was no change in time spent in hypoglycemia from T3 to T12, although there was a decreasing trend present. HbA1c values significantly decreased from baseline (T0) to 3 months (T3) ( p < 0.001), with a drop from 7.48% ± 0.1% to 7.30 ± 0.1%. An FGM sensor was placed at study entry and all participants were educated through a period of 5 days on sensor usage and self-management of glycemia with follow up visits every 3 months. This prospective observational study included 425 diabetes type 1 subjects followed up for 3 to 12 months (320 were followed up to 3 months, 267 up to 6 months and 147 up to period of one year). Thus, patients can wear it for 10–14 days with minimal disturbance of their activities of daily living.In this study, we investigated the effectiveness of FreeStyle Libre Flash Glucose Monitoring (FGM) implementation in a real life clinical setting with the emphasis on the effect of initial education on the use of the FGM system. The sensor is small and discreet, measuring approximately the size of a quarter. Appropriate therapeutic changes can then be made over the phone or through the electronic medical record/patient portal. Fourteen days after placement at a provider’s office, patients can remove the sensor and send it back to the health care provider. The Freestyle Libre Pro can be an effective tool to coordinate care in virtually any health care setting. Freestyle Libre allows valuable glucose data to be collected even if patients are inconsistent with their blood glucose monitoring. The sensor does not need to be calibrated with blood glucose meter readings to maintain accuracy. Dexcom and Medtronic CGM systems give falsely high glucose readings when a patient takes acetaminophen ( 2). The Freestyle Libre is also the only CGM system on the market with no acetaminophen interference. The time from a patient’s decision to wear a CGM device to the first delivery can often take months with other CGM systems. Unlike other CGMs on the market, Libre will not need authorizations through specialty distributers. The Freestyle Libre is available to patients through retail pharmacies. The downloading and reporting software, LibreView, is also free to the clinic. The handheld device for reading the sensor stays with the health care professional and is used for all patients. There are no reusable parts that must be sanitized between patients. Only disposable portions of the system are sent home with patients. For the Pro version, the initial cost to the clinic is minimal. The Freestyle Libre has several potential advantages. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |